<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1420">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04347876</url>
  </required_header>
  <id_info>
    <org_study_id>AssiutU12</org_study_id>
    <nct_id>NCT04347876</nct_id>
  </id_info>
  <brief_title>Outcome of COVID-19 Cases Based on Tuberculin Test: Can Previous BCG Alter the Prognosis?</brief_title>
  <official_title>Outcome of COVID-19 Cases Admitted to Hospital and ICU With Positive Tuberculin Test: Can Previous BCG Alter the Prognosis?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is no evidence that the Bacille Calmette-Gu√©rin vaccine (BCG) protects people against
      infection with COVID-19 virus. Two clinical trials addressing this question are underway, and
      WHO will evaluate the evidence when it is available. In the absence of evidence, WHO does not
      recommend BCG vaccination for the prevention of COVID-19. WHO continues to recommend neonatal
      BCG vaccination in countries or settings with a high incidence of tuberculosis. There is
      experimental evidence from both animal and human studies that the BCG vaccine has
      non-specific effects on the immune system. These effects have not been well characterized and
      their clinical relevance is unknown
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 11, 2020</start_date>
  <completion_date type="Anticipated">June 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 16, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Pneumonia severity index</measure>
    <time_frame>2 weeks</time_frame>
    <description>severity of COVID-19 pneumonia</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Need for ICU admission</measure>
    <time_frame>2 weeks</time_frame>
    <description>severe pneumonia indicating invasive or non invasive mechanical ventilation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>COVID -19 test conversion</measure>
    <time_frame>2 weeks</time_frame>
    <description>number of days to cure from COVID-19 disease</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>2 weeks</time_frame>
    <description>frequency of fatalities</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>COVID-19</condition>
  <condition>BCG Vaccination</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <description>COVID-19 positive with positive tuberculin test</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <description>COVID-19 positive with negative tuberculin test</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Tuberculin test</intervention_name>
    <description>Test the delayed hypersensitivity reaction and immunity to previous BCG vaccination</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All cases admitted with proven COVID-19 positive disease will be included, tested with
        tuberculin test positive and negative ( History of previous BCG or not)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  COVID-19 positive cases admitted to hospitals in Upper Egypt

        Exclusion Criteria:

          -  None
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>AssiutU</name>
      <address>
        <city>Assiut</city>
        <zip>71111</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aliae AR Mohamed-Hussein</last_name>
      <phone>+201222302352</phone>
      <email>aliaehussein@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 14, 2020</study_first_submitted>
  <study_first_submitted_qc>April 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 15, 2020</study_first_posted>
  <last_update_submitted>April 14, 2020</last_update_submitted>
  <last_update_submitted_qc>April 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 15, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Aliae AR Mohamed Hussein</investigator_full_name>
    <investigator_title>Professor of Pulmonology</investigator_title>
  </responsible_party>
  <keyword>Outcome</keyword>
  <keyword>COVID-19 pneumonia</keyword>
  <keyword>BCG</keyword>
  <keyword>Tuberculin test positive</keyword>
  <keyword>Egypt</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

